These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23421989)

  • 1. Histone deacetylase inhibition attenuates transcriptional activity of mineralocorticoid receptor through its acetylation and prevents development of hypertension.
    Lee HA; Lee DY; Cho HM; Kim SY; Iwasaki Y; Kim IK
    Circ Res; 2013 Mar; 112(7):1004-12. PubMed ID: 23421989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibition attenuates cardiac hypertrophy and fibrosis through acetylation of mineralocorticoid receptor in spontaneously hypertensive rats.
    Kang SH; Seok YM; Song MJ; Lee HA; Kurz T; Kim I
    Mol Pharmacol; 2015 May; 87(5):782-91. PubMed ID: 25667225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysine deacetylase inhibition attenuates hypertension and is accompanied by acetylation of mineralocorticoid receptor instead of histone acetylation in spontaneously hypertensive rats.
    Seok YM; Lee HA; Park KM; Hwangbo MH; Kim IK
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):799-808. PubMed ID: 27106211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone Deacetylase 3 and 4 Complex Stimulates the Transcriptional Activity of the Mineralocorticoid Receptor.
    Lee HA; Song MJ; Seok YM; Kang SH; Kim SY; Kim I
    PLoS One; 2015; 10(8):e0136801. PubMed ID: 26305553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysine acetyltransferases cyclic adenosine monophosphate response element-binding binding protein and acetyltransferase p300 attenuate transcriptional activity of the mineralocorticoid receptor through its acetylation.
    Seo M; Song M; Seok YM; Kang SH; Lee HA; Sohn UD; Kim IK
    Clin Exp Pharmacol Physiol; 2015 May; 42(5):559-66. PubMed ID: 25707758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity.
    Fu Y; Zhang P; Ge J; Cheng J; Dong W; Yuan H; Du Y; Yang M; Sun R; Jiang H
    Int J Biochem Cell Biol; 2014 Sep; 54():68-77. PubMed ID: 25019367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibition, but not a mineralocorticoid receptor antagonist spironolactone, attenuates atypical transcription by an activating mutant MR (MRS 810L ).
    Kang SH; Lee HA; Lee E; Kim M; Kim I
    Clin Exp Pharmacol Physiol; 2016 Oct; 43(10):995-1003. PubMed ID: 27362706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of histone deacetylases.
    Huang Y; Shaw PG; Davidson NE
    Methods Mol Biol; 2011; 791():297-311. PubMed ID: 21913088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of C/EBPβ and TSC2 by an HDAC inhibitor CG200745 protects heart from DOCA-induced hypertrophy.
    Lee E; Lee HA; Kim M; Do GY; Cho HM; Kim GJ; Jung H; Song JH; Cho JM; Kim I
    Clin Exp Pharmacol Physiol; 2019 Mar; 46(3):226-236. PubMed ID: 30099761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
    Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid-mediated neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation.
    Zhang Z; Qin X; Tong N; Zhao X; Gong Y; Shi Y; Wu X
    Exp Eye Res; 2012 Jan; 94(1):98-108. PubMed ID: 22143029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineralocorticoid receptor-mediated DNA damage in kidneys of DOCA-salt hypertensive rats.
    Schupp N; Kolkhof P; Queisser N; Gärtner S; Schmid U; Kretschmer A; Hartmann E; Oli RG; Schäfer S; Stopper H
    FASEB J; 2011 Mar; 25(3):968-78. PubMed ID: 21135038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension.
    Chen F; Li X; Aquadro E; Haigh S; Zhou J; Stepp DW; Weintraub NL; Barman SA; Fulton DJR
    Free Radic Biol Med; 2016 Oct; 99():167-178. PubMed ID: 27498117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone acetylation is not an accurate predictor of gene expression following treatment with histone deacetylase inhibitors.
    Ellis DJ; Lawman ZK; Bonham K
    Biochem Biophys Res Commun; 2008 Mar; 367(3):656-62. PubMed ID: 18179771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase as therapeutic target in a rodent model of hemorrhagic shock: effect of different resuscitation strategies on lung and liver.
    Lin T; Chen H; Koustova E; Sailhamer EA; Li Y; Shults C; Liu B; Rhee P; Kirkpatrick J; Alam HB
    Surgery; 2007 Jun; 141(6):784-94. PubMed ID: 17560255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases.
    Göttlicher M
    Ann Hematol; 2004; 83 Suppl 1():S91-2. PubMed ID: 15124690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of Transcriptional Activity of Forkhead Box O1 by Histone Deacetylase Inhibitors Ameliorates Hyperglycemia in Type 2 Diabetic Rats.
    Cho HM; Seok YM; Lee HA; Song M; Kim I
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30424007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone acetylation and expression of mono-aminergic transmitters synthetases involved in CUS-induced depressive rats.
    Liu D; Qiu HM; Fei HZ; Hu XY; Xia HJ; Wang LJ; Qin LJ; Jiang XH; Zhou QX
    Exp Biol Med (Maywood); 2014 Mar; 239(3):330-6. PubMed ID: 24495952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter specific sensitivity to inhibition of histone deacetylases: implications for hormonal gene control, cellular differentiation and cancer.
    Dressel U; Renkawitz R; Baniahmad A
    Anticancer Res; 2000; 20(2A):1017-22. PubMed ID: 10810390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.